Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase I Study of KN035, the First Subcutaneously Administered, Novel Fusion Anti-Pd-l1 Antibody in Patients with Advanced Solid Tumors in China.

Journal of Clinical Oncology(2019)

Cited 9|Views43
Key words
Antibody Engineering
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined